DAN M. GRANOFF, MD
An Overview
Scientists & Staff
Patents
Support
Publications
Links


Email
: Dan Granoff
Phone: 510-450-7640

CHORI Staff Directory
CHORI Intranet
CHORI News

Active Grant Support

Active as of March 2017

National Institutes of Allergy and Infectious Disease, NIH. RO1 AI046464.
Meningococcal serogroup B vaccine to prevent invasive disease and carriage. 
Principal Investigator, Dan M Granoff
1999-2019.

National Institutes of Allergy and Infectious Disease, NIH. R01 AI114701.
The effect of binding of FH to meningococcal Fhbp vaccine on antibody protection.
Principal Investigators, Dan M. Granoff and Peter T. Beernink
2014-2019.
                       
National Institutes of Allergy and Infectious Disease, NIH. R41 AI124759.
A universal vaccine for the prevention of meningococcal meningitis in Africa.
Role: Consultant (Principal Investigator, Greg Moe)
2016-2017.

Achillion Pharmaceuticals, Inc.
The effect of blocking the alternative complement pathway by factor D inhibitor on vaccine induced protection against meningococcal disease.
Principal Investigator, Dan M Granoff
2016-2017.

 

Revised: Thursday, March 16, 2017 8:28 AM

BUCSF

 


© 2005 Children's Hospital Oakland Research Institute
5700 Martin Luther King Jr Way • Oakland, California 94609
Phone 510-450-7600 • Fax 510-450-7910
Site MapDisclaimer